Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.640
-0.090-1.16%
Volume:90.73M
Turnover:685.07M
Market Cap:88.01B
PE:18.90
High:7.710
Open:7.600
Low:7.420
Close:7.730
Loading ...

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Anti-Tumor Indication of Sirolimus in China

MT Newswires Live
·
04 Mar

CSPC Pharmaceutical - Sirolimus for Injection (Albumin-Bound) Was Granted Breakthrough Therapy Designation in China

THOMSON REUTERS
·
28 Feb

Greater China Stocks Rise; Hong Kong Sees Largest Increase

Dow Jones
·
26 Feb

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$6.48 From HK$7.02, Keeps at Buy

MT Newswires Live
·
26 Feb

CSPC Pharmaceutical's 2024 Profit to Fall 26%; Shares Slide 4%

MT Newswires Live
·
26 Feb

BRIEF-CSPC Pharmaceutical Expects Decrease In Profit Attributable For Year Of 26%

Reuters
·
25 Feb

CSPC Pharmaceutical Sees Decrease in Profit Attributable for Year of 26%

THOMSON REUTERS
·
25 Feb

CSPC Pharmaceutical - Expected Result Due to Decrease in Revenue of Finished Drugs Business for Year

THOMSON REUTERS
·
25 Feb

Radiance Biopharma Enters Exclusive License for Ror-1 Targeted Antibody Drug Conjugate

THOMSON REUTERS
·
20 Feb

CSPC Pharmaceutical Group's Subsidiary Signs Exclusive Licensing Agreement for Cancer Drug

MT Newswires Live
·
19 Feb

BRIEF-CSPC Pharmaceutical Receives Exclusive License Agreement For SYS6005 With Radiance Biopharma

Reuters
·
19 Feb

CSPC Pharmaceutical - Exclusive License Agreement for Sys6005 With Radiance Biopharma

THOMSON REUTERS
·
19 Feb

CSPC Pharmaceutical - CSPC Megalith Will Receive Upfront Payments of US$15 Mln

THOMSON REUTERS
·
19 Feb

CSPC Pharmaceutical's Unit Gets China Nod for Marketing of New Indication of Asthma Drug

MT Newswires Live
·
11 Feb

BRIEF-Cspc Pharmaceutical Says Syh2059 Tablets Obtains Clinical Trial Approval In U.S.

Reuters
·
10 Feb

BRIEF-Cspc Pharmaceutical Says Enyitan Obtains Marketing Approval By Nmpa

Reuters
·
10 Feb

CSPC Pharmaceutical - New Indication for Enyitan Obtains Marketing Approval by Nmpa

THOMSON REUTERS
·
10 Feb

CSPC Pharmaceutical - Syh2059 Tablets Obtains Clinical Trial Approval in U.S. by US FDA

THOMSON REUTERS
·
10 Feb

CSPC Pharmaceutical Group Limited's (HKG:1093) Share Price Not Quite Adding Up

Simply Wall St.
·
10 Feb

CSPC Pharmaceutical Get China Nod for Herpes Zoster Drug Trial

MT Newswires Live
·
07 Feb